STOCKWATCH
·
Medical/Dental Instruments
Quarterly ResultMay 14, 2026, 04:03 PM

Heartflow Q1 Revenue $52.6M, +41%; Raises 2026 Guidance

AI Summary

Heartflow reported strong first-quarter 2026 financial results, with total revenue increasing 41% year-over-year to $52.6 million. The company also raised its full-year 2026 revenue guidance to $228 million-$232 million, reflecting increased growth expectations. Despite a GAAP net operating loss of $29.5 million, which included a $7.5 million impairment charge for facilities optimization, non-GAAP net operating loss was $15.5 million. The CEO highlighted strong momentum, durable growth in its FFRCT business, and ahead-of-schedule adoption of Plaque Analysis.

Key Highlights

  • Total revenue for Q1 2026 was $52.6 million, a 41% increase year-over-year.
  • Raised 2026 annual revenue guidance to $228 million-$232 million, up from $218 million-$222 million.
  • Non-GAAP gross margin for Q1 2026 was 80.5%, compared to 75.3% in the prior year period.
  • GAAP net operating loss was $29.5 million, including a $7.5 million non-cash impairment charge.
  • Non-GAAP net operating loss was $15.5 million for the quarter.
  • U.S. revenue grew 42% to $48.3 million; International revenue grew 34% to $4.3 million.
  • Cash, cash equivalents and investments totaled $254.9 million as of March 31, 2026.
HTFL
Medical/Dental Instruments
Heartflow, Inc.

Price Impact